Skip to content

Clinical trials

Diabetic Neuropathies trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetic Neuropathies Country / region: United Kingdom Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20031
20041
20051
20092
20101
20111
20121
20131
20141
20184
20222
20232
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Unknown status4
Terminated2
Withdrawn2
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company2
Glenmark Pharmaceuticals Ltd. India2
King's College London2
AstraZeneca1
Aziende Chimiche Riunite Angelini Francesco S.p.A1
BioChemics, Inc.1
Chromaderm, Inc.1
Imperial College London1
Jazz Pharmaceuticals1
MEDA Pharma GmbH & Co. KG1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetic Neuropathies24
Diabetes Mellitus9
Diabetes Complications3
Diabetes Mellitus, Type 13
Diabetes Mellitus, Type 23
Neuralgia3
Pain3
Peripheral Nervous System Diseases2
Carpal Tunnel Syndrome1
Chronic Pain1

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.